Pneumonia with bacterial and viral coinfection
1Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Purpose Of Review:
We aim to review the epidemiology of pneumonia with bacterial and viral coinfection, the pathogenesis and clinical impact of coinfection along with the current state of treatment and outcomes.
Recent Findings:
Emphasis is given to the pathogenesis of bacterial and viral co-infection including specific highlighting on influenza, rhinovirus, respiratory syncytial virus and cytomegalovirus. Updates on the current state of diagnosis and management are included, as well as on areas where future research can be directed to improve patient clinical outcomes regarding viral and bacterial coinfection.
Summary:
Bacterial and viral coinfection is increasingly recognized as an underlying etiology for community- and hospital-acquired infections. Coinfections may be a risk factor for ICU admission, severity of disease, and mortality. Clinicians must be aware of these coinfections for appropriate management and prognostication, as well as for the prevention of nosocomial spread of viral illness.
Insights
Bacterial and viral coinfections in pneumonia are increasingly recognized, impacting disease severity and mortality. Awareness and appropriate management are crucial for patient outcomes and preventing spread.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Bacterial and viral coinfections are an emerging cause of community- and hospital-acquired pneumonia.
- Understanding coinfection dynamics is vital for effective clinical management.
Purpose of the Study:
- To review the epidemiology of bacterial and viral coinfection in pneumonia.
- To explore the pathogenesis, clinical impact, and current treatment strategies for coinfections.
Main Methods:
- Literature review focusing on epidemiology, pathogenesis, and clinical outcomes.
- Synthesis of current diagnostic and management approaches.
Main Results:
- Coinfections with viruses like influenza, RSV, and CMV alongside bacteria are highlighted.
- Coinfections are linked to increased ICU admission, disease severity, and mortality.
Conclusions:
- Clinicians must recognize coinfections for improved prognostication and patient management.
- Awareness aids in preventing nosocomial spread of viral infections.
- Further research is needed to enhance patient outcomes in coinfection cases.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: